Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01GWN
|
||||
Former ID |
DNC012923
|
||||
Drug Name |
(24S)-ethylcholesta-7,9(11),22(E)-triene-3b-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527846] | ||
Structure |
Download2D MOL |
||||
Formula |
C29H46O
|
||||
Canonical SMILES |
CCC(C=CC(C)C1CCC2C1(CC=C3C2C=CC4C3(CCC(C4)O)C)C)C(C)C
|
||||
InChI |
1S/C29H46O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h8-11,15,19-26,30H,7,12-14,16-18H2,1-6H3/b9-8+/t20-,21-,22?,23+,24+,25-,26+,28+,29-/m1/s1
|
||||
InChIKey |
ZFRLPKWDPDXIMP-BLDYNFBXSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cholinesterase | Target Info | Inhibitor | [527846] | |
Acetylcholinesterase | Target Info | Inhibitor | [527846] | ||
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.